by Alexandra Calescibetta, Robert Dalton, Nicole Fortenbery, Grace Ward, Sean Christiansen, Xianghong Chen, Pingyan Cheng, Tiffany Razabdouski, Annelise J. Glode, Nhan Tu, Thu Le Trinh, Jinghong Liu, Kenneth L. Wright, Sheng Wei, Erika Adriana Eksioglu
PLOS ONE (Medicine) published a clinical update in Research Highlights on 22 Apr 2026.
The item focuses on Correction: Combining lenalidomide with IL-2 family of cytokines enhances activating receptor and perforin/granzyme expression in NK cells.
Review the original article for the full source wording and details.